Preclinical and clinical investigations have revealed the promising potential of various fibroblast-activating protein inhibitor (FAPI) radiopharmaceuticals. One strategy of particular interest involves the covalent targeting of these FAPI-based agents to fibr... ...

请注册登录后继续浏览